Assessment of Tumor Regression by Consecutive Pelvic Magnetic Resonance Imaging and Dose Modification during High- Dose-Rate Brachytherapy for Carcinoma of the Uterine Cervix

키워드

참고문헌 (23)

1. "Invasive cervical carcinoma:role of MR imaging inpretreatment work-up--cost minimization and diagnostic efficacyanalysis", 198, pp.403~9 (1996)
2. "Image fusion of CT and MRI data enables improvedtarget volume definition in 3D-brachytherapy treatment planning", 2, pp.164~71 (2003)
3. "Magnetic resonance imaging in the treatmentplanning of radiation therapy in carcinoma of the cervixtreated with the four-field pelvic technique", 37, pp.827~32 (1997)
4. "The impact of sectional imaging on dose escalationin endocavitary HDR-brachytherapy of cervical cancer:results of a prospective comparative trial", 68, pp.51~9 (2003)
5. "Evaluation of the therapeutic effect of radiotherapy oncervical cancer using magnetic resonance imaging", 45, pp.639~44 (1999)
6. "Determination of tumour regression rates during radiotherapyfor cervical carcinoma by serial MRI:comparison oftwo measurement techniques and examination of intraobserverand interobserver variability", 72, pp.62~72 (1999)
7. "Cervical cancer:serial MR imaging before andafter primary radiation therapy--a 2-year follow-up study", 184, pp.89~93 (1992)
8. "Clinical evaluation using magnetic resonance imagingfor patients with stage III cervical carcinoma treated by radiationalone in multicenter analysis:its usefulness and limitationsin clinical practice", 26, pp.574~83 (2003)
9. "Tumor diameter and volumeassessed by magnetic resonance imaging in the prediction ofoutcome for invasive cervical cancer", 82, pp.474~82 (2001)
10. "Interfractional variation in positionof the uterus during radical radiotherapy for cervical cancer", 71, pp.73~9 (2004)
11. "Dose and volume specification for reporting intracavitarytherapy in gynecology", pp.1~38 20
12. "Toxicity criteria of the RadiationTherapy Oncology Group (RTOG) and the European Organizationfor Research and Treatment of Cancer (EORTC).", pp.1341~6 (1995)
13. "Major geometric variations between multiplehigh-dose-rate applications of brachytherapy in cancer of thecervix:frequency and types of variation", 195, pp.419~22 (1995)
14. "Changes inapplicator position with fractionated high dose rate gynaecologicalbrachytherapy", 40, pp.59~62 (1996)
15. "Current status of high dose rate brachytherapy incervical cancer in Korea and optimal treatment schedule", 16, pp.357~66 (1998)
16. "Proposed guidelines for image-based intracavitary brachytherapyfor cervical carcinoma:report from Image-GuidedBrachytherapy Working Group", 60, pp.1160~72 (2004)
17. "Design of an afterloadingvaginal applicator (MIRALVA).", pp.1503~8 (1990)
18. "A novel applicator for low-dose-rate brachytherapy ofgynecological cancers", 13, pp.532~40 (2003)
19. "Tumor size evaluated by pelvic examination comparedwith 3-D quantitative analysis in the prediction ofoutcome for cervical cancer", 39, pp.395~404 (1997)
20. "Dose optimization offractionated external adiation and high-dose-rate intracavitarybrachytherapy for FIGO stage IB uterine cervical carcinoma", 52, pp.1338~44 (2002)
21. "The prediction of late rectal complications inpatients treated with high dose-rate brachytherapy for carcinomaof the cervix", 38, pp.989~93 (1997)
22. "High-dose-rate brachytherapyin the treatment of uterine cervix cancer. Analysis of doseeffectiveness and late complications", 50, pp.1123~35 (2001)
23. "High-dose-rate versus low-dose-rate intracavitarybrachytherapy for carcinoma of the cervix", 19, pp.791~6 (1990)

관련 논문AI추천